| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26.7M | +173.6% |
| SG&A Expense | $26.1M | +194.0% |
| Operating Income | -$52.8M | -1136.4% |
| Pre-tax Income | -$72.9M | -506.1% |
| Income Tax | $683K | -88.8% |
| Net Income | -$73.6M | -720.3% |
| EPS (Basic) | -$0.74 | -57.4% |
| EPS (Diluted) | -$0.74 | -57.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97.1M | +5863.8% |
| Current Assets | $231.9M | — |
| Total Assets | $281.7M | -7.8% |
| Current Liabilities | $5.3M | +52.8% |
| Total Liabilities | $30.9M | +191.8% |
| Stockholders' Equity | $250.9M | +3093.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.4M | -254.0% |
| Capital Expenditures | $352K | +324.1% |
| Investing Cash Flow | -$175.8M | -178.2% |
| Financing Cash Flow | $301.4M | +239.6% |
| Free Cash Flow | -$38.7M | -254.5% |